Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Compass Therapeutics, Inc. | CFO | Common Stock | 400K | $660K | $1.65 | Dec 9, 2024 | Direct |
TREVENA INC | Acting COO and CFO | Common Stock | 11.5K | $17K | $1.47 | Oct 8, 2024 | Direct |
Compass Therapeutics, Inc. | CFO | Stock Option (Right to Buy) | 400K | Dec 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CMPX | Compass Therapeutics, Inc. | Dec 9, 2024 | 2 | $660K | 4 | Dec 10, 2024 | CFO |
CMPX | Compass Therapeutics, Inc. | Dec 9, 2024 | 0 | $0 | 3 | Dec 10, 2024 | CFO |
TRVN | TREVENA INC | Oct 8, 2024 | 5 | -$1.18K | 4 | Oct 10, 2024 | Acting COO and CFO |
TRVN | TREVENA INC | Sep 14, 2024 | 1 | -$18 | 4 | Sep 17, 2024 | SVP, CFO |
TRVN | TREVENA INC | Dec 14, 2023 | 3 | $141K | 4 | Dec 15, 2023 | SVP, CFO |
TRVN | TREVENA INC | Dec 2, 2023 | 3 | -$2.97K | 4 | Dec 5, 2023 | SVP, CFO |
TRVN | TREVENA INC | Sep 14, 2023 | 1 | -$50 | 4 | Sep 18, 2023 | SVP, CFO |
TRVN | TREVENA INC | Jun 26, 2023 | 1 | -$606 | 4 | Jun 28, 2023 | SVP, CFO |
TRVN | TREVENA INC | Jan 6, 2023 | 1 | $0 | 4 | Jan 6, 2023 | SVP, CFO |
TRVN | TREVENA INC | Dec 17, 2022 | 1 | -$640 | 4 | Dec 20, 2022 | SVP, CFO |
TRVN | TREVENA INC | Dec 2, 2022 | 1 | -$4K | 4 | Dec 6, 2022 | SVP, CFO |
TRVN | TREVENA INC | Sep 14, 2022 | 1 | -$369 | 4 | Sep 16, 2022 | SVP, CFO |
TRVN | TREVENA INC | Jun 28, 2022 | 1 | -$13K | 4 | Jun 29, 2022 | SVP, CFO |
TRVN | TREVENA INC | Dec 17, 2021 | 1 | -$9.95K | 4 | Dec 21, 2021 | SVP, CFO |
TRVN | TREVENA INC | Dec 6, 2021 | 1 | -$22.4K | 4 | Dec 8, 2021 | SVP, CFO & CCO |
TRVN | TREVENA INC | Dec 2, 2021 | 1 | $0 | 4 | Dec 3, 2021 | SVP, CFO & CCO |
TRVN | TREVENA INC | Sep 14, 2021 | 2 | $0 | 4 | Sep 16, 2021 | Chief Financial Officer |
TRVN | TREVENA INC | Jun 25, 2021 | 1 | -$48.3K | 4 | Jun 25, 2021 | Chief Financial Officer |